Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Interferon vs Biochemotherapy in High-Risk Melanoma
NCT00006237Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Aug 2000
- Primary completion
- Jul 2012
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), vinblastine, dacarbazine, aldesleukin, interferon alfa-2b in cutaneous melanoma (CM), sponsored by SWOG Cancer Research Network. Started Aug 2000; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)vinblastinedacarbazinealdesleukininterferon alfa-2b
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT00006237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006237.